Navigation Links
Study to identify best rehabilitation therapies for patients with traumatic brain injuries
Date:12/15/2008

e methodology has been used successfully to improve treatment for stroke.

Traumatic brain injury occurs when the head suddenly and violently hits an object, as in a fall or car crash, or when an object, such as a bullet, pierces the skull and enters brain tissue. Symptoms of a traumatic brain injury can be mild, moderate, or severe, and vary depending on the extent and location of the brain damage. For patients with moderate or severe injuries, symptoms range from headaches and lethargy to convulsions, loss of coordination, confusion, cognitive deficits, and behavior and mood changes.

Research to date has done little to help identify the best treatments for the range of symptoms. Randomized clinical trials of rehabilitation therapies, for example, typically evaluate only specific treatments for a select group of patients. Results are not general enough to apply to the whole population of traumatic brain injury patients.

By isolating individual components of therapy as applied to patients with different degrees of traumatic brain injuries, the researchers expect to be able to prescribe best practices for rehabilitation, raising the standard of treatment in facilities all across the country.

"From the extraordinary wealth of data we'll collect in this five-year analysis, we will be able to offer clinicians the information that can help them evaluate their current treatment practices and select therapies that are most likely to help their patients," Young said. "This is medicine at its best: treatment based on the results of years of clinical practice."


'/>"/>

Contact: Sharon Butler
sharon_butler@rush.edu
312-942-7816
Rush University Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Double Blind Study Proves The Pink Patch Works for Weight Loss
2. First Patient from CyberKnife Center of Palm Beach Enrolled in Worldwide Landmark Study of Operable Lung Cancer Patients
3. Planned safety analysis of a breast cancer prevention study reveals encouraging news for Exemestane
4. Genomic Health Announces Study Establishing the Utility of Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated with Aromatase Inhibitors
5. Wyeth Announces Positive Data from Phase 2 Study of Neratinib in Advanced HER-2-Positive Breast Cancer
6. Partnership for a Drug-Free America(R) Responds to 2008 Monitoring the Future Study Results
7. UB driver simulation study targets high-risk teenage drivers
8. Employer Vantage From HealthLeaders-InterStudy Provides a Snapshot of Both Self- and Fully-Insured Health Benefits to Help Pharmaceutical and Diagnostic Manufacturers Identify Business Opportunities
9. Study shows major pain research funding decline at NIH
10. Womens magazines downplay emotional health risks of cosmetic surgery: UBC study
11. Study Asks: Are Physicians Overusing an Invasive Cardiac Treatment?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... May 23, 2013 Former United States ... for Acadian 's annual Paramedic Luncheon. , ... Convention Center, Cheney praised Acadian's medics, saying, "I am ... participate in awarding the Paramedic of the Year Award. ... is a lot of competition within a company like ...
(Date:5/23/2013)... Spring and summer have always been motivation for ... , the city between Memphis and Nashville? In the last ... centers has transformed the growing area into one of the ... city of vibrant, young professionals you are going to see ... White, owner of The Fight Shop, one of the city’s ...
(Date:5/23/2013)... 2013 On April 29th, 2013, UV ... growing numbers of H7N9 cases and deaths. The headline read, ... Cases Will Subside in Northern Hemisphere as Available Daylight Increases ... have been reported. , Quoting Kevin McGuire, president of ... as flowers budding in the spring and leaves changing in ...
(Date:5/23/2013)... May 23, 2013 Parker Waichman LLP, ... of victims injured by defective medical devices and drugs, ... J. McCauley has been appointed Co-Lead Counsel in the ... Products Liability Litigation (Case 7:13-md-02434-CS). The Order, which was ... Counsel are to submit their proposal for the Court’s ...
(Date:5/23/2013)... EnvirOasis, the leader in energy efficient lighting ... pleased to announce its new line of Energy Star ... EnvirOasis has been a market leader in Fluorescent and ... has recently brought to market a full line of ... energy efficient lighting technology which produces a very high ...
Breaking Medicine News(10 mins):Health News:Acadian Ambulance Honors Paramedic of the Year at Annual Luncheon 2Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 2Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 3Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 4Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 2Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 3Health News:U.S. District Court Appoints Parker Waichman LLP’s Matthew J. McCauley to Leadership Role in Mirena IUD Litigation 2Health News:EnvirOasis Lighting Announces Energy Star and Design Lights Consortium LED Products 2
... with a history of severe milk allergy can safely drink ... research led by the Johns Hopkins Children,s Center and published ... of Allergy and Clinical Immunology . Investigators followed up ... earlier Hopkins Children,s-led study published in 2008 in which patients ...
... , NEW YORK, NY, Aug. 18 /PRNewswire-FirstCall/ - (OTCBB: ... that identifies, acquires, and develops novel drug targets that ... Whiteman as its Chief Executive Officer. , Mr. Whiteman, ... London School of Economics . He will provide ...
... , Miami ... Area , , ... today to participating in a conspiracy to defraud the Medicare program of ... Division, U.S. Attorney Terrence Berg of the Eastern District of Michigan and ...
... , HATBORO, Pa., Aug. 18 ... IFLG ), a leading technology provider of enterprise ... that it has successfully achieved Motorola,s Enterprise Mobility Validation for ... Controller (MDC), InfoLogix,s innovative application platform for mobile ...
... , MOUNT PROSPECT, Ill., Aug. 18 The ... KnujOn for spotlighting the exploitation of search engines, advertising programs ... Prescription Drug Sponsored Search Results," released on August 18, 2009, ... Yahoo!,s online advertising program. , , ...
... , PRINCETON, N.J., Aug. 18 Covance (NYSE: ... with Merck to provide a broad array of genomics analysis services ... Gene Expression Laboratory. Effective August 17, 2009, Covance assumed control ... , About Covance , Covance, with ...
Cached Medicine News:Health News:Milk is safe, even encouraged, for some children after treatment for milk allergy 2Health News:GENova names Aaron Whiteman as CEO 2Health News:GENova names Aaron Whiteman as CEO 3Health News:Detroit Clinic Owner and Patient Recruiter Plead Guilty in $15 Million Fraud Scheme 2Health News:Detroit Clinic Owner and Patient Recruiter Plead Guilty in $15 Million Fraud Scheme 3Health News:Detroit Clinic Owner and Patient Recruiter Plead Guilty in $15 Million Fraud Scheme 4Health News:InfoLogix Achieves Motorola Enterprise Mobility Validation 2Health News:InfoLogix Achieves Motorola Enterprise Mobility Validation 3Health News:NABP Applauds LegitScript and KnujOn for Spotlighting Exploitation of Internet Ad Programs by Rogue Internet Drug Outlets 2Health News:Covance and Merck & Co., Inc. Finalize Strategic Agreement 2
(Date:5/23/2013)... SAN DIEGO , May 23, 2013 /PRNewswire/ ... the prostate cancer treatment continuum was highlighted prominently ... the American Urological Association (AUA), in San Diego.  ... invasive high intensity focused ultrasound (HIFU) technology, the ... localize disease, and for urologists to consider minimally ...
(Date:5/23/2013)... -- Spring Bank Pharmaceuticals, Inc., a biopharmaceutical company developing innovative ... that it has initiated dosing in a Phase I ... therapy for the treatment of HCV infection. This study will ... to assess both the safety and antiviral efficacy of ... the treatment of chronic HCV infections and is based ...
(Date:5/23/2013)... AVIV, Israel , May 23, 2013 ... BrainTech Israel 2013 , Israel,s ... place on October 14 th -15 th in ... nd most innovative city in the world by the ... "Start-up Nation." BrainTech Israel 2013 will showcase the ...
Breaking Medicine Technology:Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3
... in Excess of $10 Million; Access Gains Second ... SEOUL, South Korea, Feb. 19 ... and JCOM Ltd , an ... the Republic of Korea, today announced the signing of ...
... Were Performed on AMI Patients in 2008, According to ... Millennium Research Group,s (MRG,s) US Markets for Interventional ... stents will continue to climb steadily through 2013, driven ... coronary intervention (PCI) in Acute Myocardial Infarction (AMI) patients, ...
Cached Medicine Technology:Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea 2Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea 3Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea 4Adoption of PCI in AMI Patients to Drive Drug-Eluting Stent Use 2
... is for arthroscopic and open soft tissue repair ... procedural steps. It may be used with ... in conjunction with,anchors or screws (including suture pre-assembled ... tip permits the placement of a variety of ...
Knot pusher/suture retriever...
... The RC Retractor comes ... allow for superficial or deep ... Retractor permits retraction in three ... inferior. The fiber optic ...
Shoulder rasp...
Medicine Products: